Annual D&A
$816.00 K
+$98.00 K+13.65%
30 April 2024
Summary:
KalVista Pharmaceuticals annual depreciation & amortization is currently $816.00 thousand, with the most recent change of +$98.00 thousand (+13.65%) on 30 April 2024. During the last 3 years, it has risen by +$279.00 thousand (+51.96%). KALV annual D&A is now at all-time high.KALV Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$224.00 K
+$5000.00+2.28%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly depreciation & amortization is currently $224.00 thousand, with the most recent change of +$5000.00 (+2.28%) on 31 July 2024. Over the past year, it has increased by +$27.00 thousand (+13.71%). KALV quarterly D&A is now at all-time high.KALV Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$847.00 K
+$31.00 K+3.80%
31 July 2024
Summary:
KalVista Pharmaceuticals TTM depreciation & amortization is currently $847.00 thousand, with the most recent change of +$31.00 thousand (+3.80%) on 31 July 2024. Over the past year, it has increased by +$70.00 thousand (+9.01%). KALV TTM D&A is now at all-time high.KALV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.7% | +13.7% | +9.0% |
| 3 y3 years | +52.0% | +76.4% | +58.3% |
| 5 y5 years | +115.9% | +76.4% | +79.1% |
KALV Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +52.0% | at high | +76.4% | at high | +58.3% |
| 5 y | 5 years | at high | +115.9% | at high | +76.4% | at high | +79.1% |
| alltime | all time | at high | +2922.2% | at high | at high | +8370.0% |
KalVista Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $224.00 K(+2.3%) | $847.00 K(+3.8%) |
| Apr 2024 | $816.00 K(+13.6%) | $219.00 K(+5.8%) | $816.00 K(+3.9%) |
| Jan 2024 | - | $207.00 K(+5.1%) | $785.00 K(+1.0%) |
| Oct 2023 | - | $197.00 K(+2.1%) | $777.00 K(+3.2%) |
| July 2023 | - | $193.00 K(+2.7%) | $753.00 K(+4.9%) |
| Apr 2023 | $718.00 K(+27.3%) | $188.00 K(-5.5%) | $718.00 K(+4.7%) |
| Jan 2023 | - | $199.00 K(+15.0%) | $686.00 K(+7.9%) |
| Oct 2022 | - | $173.00 K(+9.5%) | $636.00 K(+7.8%) |
| July 2022 | - | $158.00 K(+1.3%) | $590.00 K(+4.6%) |
| Apr 2022 | - | $156.00 K(+4.7%) | $564.00 K(+2.9%) |
| Apr 2022 | $564.00 K(+5.0%) | - | - |
| Jan 2022 | - | $149.00 K(+17.3%) | $548.00 K(+2.4%) |
| Oct 2021 | - | $127.00 K(-3.8%) | $535.00 K(-1.1%) |
| July 2021 | - | $132.00 K(-5.7%) | $541.00 K(+0.7%) |
| Apr 2021 | $537.00 K(+4.9%) | $140.00 K(+2.9%) | $537.00 K(+1.9%) |
| Jan 2021 | - | $136.00 K(+2.3%) | $527.00 K(+0.4%) |
| Oct 2020 | - | $133.00 K(+3.9%) | $525.00 K(+1.2%) |
| July 2020 | - | $128.00 K(-1.5%) | $519.00 K(+1.4%) |
| Apr 2020 | $512.00 K(+35.4%) | $130.00 K(-3.0%) | $512.00 K(+1.6%) |
| Jan 2020 | - | $134.00 K(+5.5%) | $504.00 K(+6.6%) |
| Oct 2019 | - | $127.00 K(+5.0%) | $473.00 K(+5.3%) |
| July 2019 | - | $121.00 K(-0.8%) | $449.00 K(+18.8%) |
| Apr 2019 | $378.00 K | $122.00 K(+18.4%) | $378.00 K(+23.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | $103.00 K(0.0%) | $307.00 K(+20.9%) |
| Oct 2018 | - | $103.00 K(+106.0%) | $254.00 K(+28.3%) |
| July 2018 | - | $50.00 K(-2.0%) | $198.00 K(+10.0%) |
| Apr 2018 | $180.00 K(+350.0%) | $51.00 K(+2.0%) | $180.00 K(+39.5%) |
| Jan 2018 | - | $50.00 K(+6.4%) | $129.00 K(+63.3%) |
| Oct 2017 | - | $47.00 K(+46.9%) | $79.00 K(+146.9%) |
| July 2017 | - | $32.00 K(>+9900.0%) | $32.00 K(-53.6%) |
| Apr 2017 | $40.00 K(+21.2%) | - | - |
| Sept 2016 | - | $0.00(0.0%) | $69.00 K(-32.4%) |
| June 2016 | - | $0.00(-100.0%) | $102.00 K(-25.0%) |
| Apr 2016 | $33.00 K(-75.2%) | - | - |
| Mar 2016 | - | $34.00 K(-2.9%) | $136.00 K(+2.3%) |
| Dec 2015 | $133.00 K(+250.0%) | $35.00 K(+6.1%) | $133.00 K(+15.7%) |
| Sept 2015 | - | $33.00 K(-2.9%) | $115.00 K(+16.2%) |
| June 2015 | - | $34.00 K(+9.7%) | $99.00 K(+32.0%) |
| Apr 2015 | $38.00 K(-29.6%) | - | - |
| Mar 2015 | - | $31.00 K(+82.4%) | $75.00 K(+38.9%) |
| Dec 2014 | $54.00 K(+100.0%) | $17.00 K(0.0%) | $54.00 K(+45.9%) |
| Sept 2014 | - | $17.00 K(+70.0%) | $37.00 K(+85.0%) |
| June 2014 | - | $10.00 K(0.0%) | $20.00 K(+100.0%) |
| Mar 2014 | - | $10.00 K | $10.00 K |
| Dec 2013 | $27.00 K(-28.9%) | - | - |
| Dec 2012 | $38.00 K | - | - |
FAQ
- What is KalVista Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual D&A year-on-year change?
- What is KalVista Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly D&A year-on-year change?
- What is KalVista Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals TTM D&A year-on-year change?
What is KalVista Pharmaceuticals annual depreciation & amortization?
The current annual D&A of KALV is $816.00 K
What is the all time high annual D&A for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual depreciation & amortization is $816.00 K
What is KalVista Pharmaceuticals annual D&A year-on-year change?
Over the past year, KALV annual depreciation & amortization has changed by +$98.00 K (+13.65%)
What is KalVista Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of KALV is $224.00 K
What is the all time high quarterly D&A for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly depreciation & amortization is $224.00 K
What is KalVista Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, KALV quarterly depreciation & amortization has changed by +$27.00 K (+13.71%)
What is KalVista Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of KALV is $847.00 K
What is the all time high TTM D&A for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high TTM depreciation & amortization is $847.00 K
What is KalVista Pharmaceuticals TTM D&A year-on-year change?
Over the past year, KALV TTM depreciation & amortization has changed by +$70.00 K (+9.01%)